
Imulux, a pioneer in optical coherence tomography, showcased its FDA-cleared technology, Niris, at the World Congress of Endourology in Cleveland last week. Unlike other optical imaging tools that focus on the breast or brain, Niris renders images of the prostate. The system achieves a spatial resolution of 0.01 mm, which is well beyond the reach of diagnostic ultrasound.























